EUVIMEDEUVIMED entdecken
Crossref

β2-Microglobulin: A potential novel prognostic indicator for neuroblastoma

Yan Lei, Jianjun Zhu, Xiaoning Liu, Yuantao Zhou, Li Li

Neurological Sciences · 2025

DOI: 10.1007/s10072-025-08470-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurological Sciences, 2025. Verfasst von Yan Lei und 4 weiteren Autor:innen. Beteiligte Einrichtung: Kunming Medical University, No. 1168 Chunrong West Road, Yuhua Street, Chenggong District, Kunming, 650500, Yunnan, China. Hauptthemen laut MEDLINE: Neuroblastoma, beta 2-Microglobulin, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Applied Basic Research Key Project of Yunnan, Cultivating Plan Program for the Leader in Science and Technology of Yunnan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Neuroblastoma is a prevalent malignant tumor in children, with significant challenges in prognosis assessment. This study investigated the potential value of β2-microglobulin for predicting outcomes in patients with intermediate- to high-risk neuroblastoma. METHODS: We conducted a retrospective analysis of 40 patients with intermediate- to high-risk NB treated at the Children's Hospital of Kunming Medical University from 2018-2021. Peripheral blood and tissue samples were collected, and relevant biomarkers were detected via flow cytometry and real-time quantitative PCR (RT-qPCR). RESULTS: β2-microglobulin was the only biomarker significantly associated with NB prognosis. Patients in the high-expression group had a significantly greater three-year survival rate than those in the low-expression group (P < 0.01). Logistic regression analysis, combined with clinical data and receiver operating characteristic curves, indicated that β2-microglobulin had predictive capabilities comparable to those of neuron-specific enolase, suggesting its potential role in treatment assessment and prognostic evaluation. CONCLUSION: β2-microglobulin has significant prognostic value in intermediate- to high-risk neuroblastoma patients and may serve as an effective biomarker for clinical prognosis. These findings offer new insights for individualized neuroblastoma treatment, emphasizing the need for future research on its applicability in diverse populations and potential use in treatment monitoring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroblastomabeta 2-MicroglobulinBiomarkers, TumorHumansFemaleMaleRetrospective StudiesPrognosisChild, PreschoolInfantChild

Stichwörter der Autor:innen

BiomarkersNSENeuroblastomaPrognostic biomarkerβ2-microglobulin

Substanzen

beta 2-MicroglobulinBiomarkers, TumorB2M protein, human

Autor:innen und Institutionen

  • Kunming Medical University, No. 1168 Chunrong West Road, Yuhua Street, Chenggong District, Kunming, 650500, Yunnan, China.
  • Maternal and Child Health Hospital of Hubei Province, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430070, China.
  • Department of Oncology, Kunming Children's Hospital, No. 288 Qianxing Road, Xishan District, Kunming, 650228, Yunnan, China.
  • Department of Pharmacy, Kunming Children's Hospital, No. 288 Qianxing Road, Xishan District, Kunming, 650228, Yunnan, China.
  • Yunnan Medical Center for Pediatric Diseases, Kunming Key Laboratory of Children Infection and Immunity, Yunnan Key Laboratory of Children's Major Disease Research, Yunnan Province Clinical Research Center for Children'…
  • Kunming Medical University, No. 1168 Chunrong West Road, Yuhua Street, Chenggong District, Kunming, 650500, Yunnan, China. lily20020302@hotmail.com.

Förderung

  • National Natural Science Foundation of China
  • Applied Basic Research Key Project of Yunnan
  • Cultivating Plan Program for the Leader in Science and Technology of Yunnan Province
  • unnan Provincial Health and Health Commission Medical High-end Talent Training Program
  • Medical Science and Technology Project of Zhejiang Province
  • Key Laboratory Project for Major Diseases in Children of Yunnan Province
  • Fund Project of Clinical Medical Research Center for Child Health and Disease in Yunnan Province.

Zitieren

APA

Lei, Y., Zhu, J., Liu, X., Zhou, Y., & Li, L. (2025). β2-Microglobulin: A potential novel prognostic indicator for neuroblastoma. Neurological Sciences. https://doi.org/10.1007/s10072-025-08470-7

Vancouver

Lei Y, Zhu J, Liu X, Zhou Y, Li L. β2-Microglobulin: A potential novel prognostic indicator for neuroblastoma. Neurological Sciences. 2025. doi:10.1007/s10072-025-08470-7

BibTeX
@article{Lei2025,
  author = {Lei, Yan and Zhu, Jianjun and Liu, Xiaoning and Zhou, Yuantao and Li, Li},
  title = {β2-Microglobulin: A potential novel prognostic indicator for neuroblastoma},
  journal = {Neurological Sciences},
  year = {2025},
  doi = {10.1007/s10072-025-08470-7}
}
Kostenlos starten →